title: Septic shock due to Legionella pneumophila serogroup 2: usefulness of molecular biology for diagnosis, treatment and epidemiological investigation.
authors.forename: Florence
authors.initials: F
authors.lastname: Grattard
authors.forename: Séverine
authors.initials: S
authors.lastname: Allegra
authors.forename: Jerome
authors.initials: J
authors.lastname: Morel
authors.forename: Isabelle
authors.initials: I
authors.lastname: Court-Fortune
authors.forename: Christian
authors.initials: C
authors.lastname: Auboyer
authors.forename: Bruno
authors.initials: B
authors.lastname: Pozzetto
authors.forename: Philippe
authors.initials: P
authors.lastname: Berthelot
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016952:Legionella pneumophila / Q000145:classification*; D007877:Legionnaires' Disease / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D008875:Middle Aged; D008967:Molecular Biology; D012772:Shock, Septic / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents